Latest News

Tolebrutinib – A New Era of MS Treatments Targeting Progression in Non-Relapsing MS

May 28, 2025 | Life with MS, News, Treatments, Uncategorised

Tolebrutinib is the first and only disease modifying therapy (DMT) showing positive signs of slowing progression in non-relapsing secondary progressive MS (SPMS). While current DMTs focus on dampening the inflammatory aspects of MS, this significant breakthrough heralds a potential new […]